FDA OKs Marketing of AI-enabled Stroke Alert for Providers
DHIT2018-02-20T08:40:43-05:00By Meg Bryant | February 15, 2018 Dive Brief: The Food and Drug Administration permitted the marketing of Viz.AI’s clinical decision support software, which analyzes computed tomography brain scans and alerts clinicians if a patient is at risk of a stroke. The Viz.AI Contact application was cleared for marketing via [...]